Do Long-Acting Injectable Antipsychotics Prevent or Delay Hospital Readmission?

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Category: VOL 48 No. 3 Articles - 2018 Tags: adherence, antipsychotic, Heather Rozea, hospitalization, Jamie C. Barner, Lisa M. Mican, long-acting-injectable, readmission, Thomas J. Maestri

Description
Reviews (0)

Description

Original Research

Do Long-Acting Injectable Antipsychotics Prevent or Delay Hospital Readmission?
By Thomas J. Maestri, Lisa M. Mican, Heather Rozea, Jamie C. Barner

08-15_PB-48-3-2018-Maestri

Reviews

There are no reviews yet.

Be the first to review “Do Long-Acting Injectable Antipsychotics Prevent or Delay Hospital Readmission?”

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Do Long-Acting Injectable Antipsychotics Prevent or Delay Hospital Readmission?

Description

Original Research

Reviews

Related products

Antipsychotic Induced Symptomatic Hyperprolactinemia

Effects of Discontinuation of Paliperidone Long-Acting Injectable After Switching from Risperidone Long-Acting Injectable Switching

Psychopharmacology Bulletin VOL 48 No. 3, 2018 – Full Issue Stacked PDF

Identifying Predictors of Primary Adherence to Second Generation Long-Acting Injectable Antipsychotics Following Discharge from an Acute Inpatient Psychiatry Unit